Mutational Status of theTP53Gene As a Predictor of Response and Survival in Patients With Chronic Lymphocytic Leukemia: Results From the LRF CLL4 Trial

Published 2011 View Full Article

Authors

Keywords

Journal

JOURNAL OF CLINICAL ONCOLOGY

Volume 29, Issue 16, Pages 2223-2229

Publisher

American Society of Clinical Oncology (ASCO)

Online

2011-04-12

DOI

10.1200/jco.2010.32.0838

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

JOURNAL OF CLINICAL ONCOLOGY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Add your recorded webinar

Ask a Question. Answer a Question.